{"id":176504,"date":"2018-01-11T11:42:05","date_gmt":"2018-01-11T11:42:05","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=176504"},"modified":"2018-01-11T11:42:05","modified_gmt":"2018-01-11T11:42:05","slug":"biobanking-market-forecasts-20172027-discover-prospects-for-medical-research-and-therapeutic-uses-including-human-tissues-fluids-and-stem-cells-leading-biobanking","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/biobanking-market-forecasts-20172027-discover-prospects-for-medical-research-and-therapeutic-uses-including-human-tissues-fluids-and-stem-cells-leading-biobanking_176504.html","title":{"rendered":"Biobanking Market Forecasts 2017-2027: Discover Prospects for Medical Research and Therapeutic Uses, Including Human Tissues, Fluids and Stem Cells, Leading Biobanking"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
“Biobanking for Therapeutic Use Revenue.”<\/div>\n<\/div>\n<\/div>\n
Our 259-page report provides 144 tables, charts, clearly illustrating the data presented in this research. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted drug sales at overall world market regional level, as well as giving a deep insight into the pipeline for Biobanking. See financial results, trends, opportunities, and revenue predictions.<\/div>\n

Report Details<\/h4>\n

Biobanking – our new study reveals trends, R&D progress, and predicted revenues<\/strong>
Where is the Biobanking market heading? If you are involved in this sector you must read this brand new report. Visiongain’s report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.<\/p>\n

Discover How to Stay Ahead<\/strong>
Our 259-page report provides 144 tables, charts, clearly illustrating the data presented in this research. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted drug sales at overall world market regional level, as well as giving a deep insight into the pipeline for Biobanking. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Biobanking market. See how to exploit these opportunities.<\/p>\n

Forecasts to 2027 and other analyses reveal the commercial prospects<\/strong>
• In addition to revenue forecasting to 2027, our new study provides you with recent results, R&D overview, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.<\/p>\n

Discover sales predictions for the world market and following Biobanking Submarkets:
• Biobanking for Research<\/strong>
• Human Tissue
• Commercial
• Public
• Stem Cells
• Others (DNA, Blood fluids etc.)<\/p>\n

Report Details<\/h4>\n

Biobanking – our new study reveals trends, R&D progress, and predicted revenues<\/strong>
Where is the Biobanking market heading? If you are involved in this sector you must read this brand new report. Visiongain’s report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.<\/p>\n

Discover How to Stay Ahead<\/strong>
Our 259-page report provides 144 tables, charts, clearly illustrating the data presented in this research. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted drug sales at overall world market regional level, as well as giving a deep insight into the pipeline for Biobanking. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Biobanking market. See how to exploit these opportunities.<\/p>\n

Forecasts to 2027 and other analyses reveal the commercial prospects<\/strong>
• In addition to revenue forecasting to 2027, our new study provides you with recent results, R&D overview, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.<\/p>\n

Discover sales predictions for the world market and following Biobanking Submarkets:
• Biobanking for Research<\/strong>
• Human Tissue
• Commercial
• Public
• Stem Cells
• Others (DNA, Blood fluids etc.)<\/p>\n

Companies mentioned unclude:<\/p>\n

 <\/p>\n

Companies Listed<\/h4>\n

Abbott Laboratories
AIS
AKH Biobank
AllCells
American CryoStem
American Type Culture Collection
Analytical Biological Services
ARUP Laboratories
ASPREE Healthy Ageing Biobank
Assure Immune
Asterand
AstraZeneca
Aurora Biomed
Auto scribe Informatics
Bangalore Brain Bank
Barts Gynae Tissue Bank
Bayer
BBMRI
Beckman Coulter
BINDER
Bio Fortis
Bio Life Solutions
Bio Repository Resources
BioCision
Biogenea
Biomatrica
Biopta
BioreclamationIVT
BioRep
BioServe Biotechnologies
BioSHARE
Biovault Technical
BIOVIA
BrainNet Europe
Bristol-Myers Squibb
Brooks Automation (acquired Bio Storage Technologies)
Brooks Life Science Systems
Caladrius Biosciences
Cambridge Biomedical Research Centre
CARTaGENE
CCLG Tissue Bank
Cells4Life
Celltex Therapeutics
Cesca Therapeutics
China Cord Blood Corp.
China Kadoorie Biobank
CLB\/Amsterdam Medical Center
CMD Biobank
CONCOR
CorCell
Cord Blood America
Cord Life
CORE Informatics
Coriell Institute for Medical Research
Cryo Bio System
Cryo-Cell
Cryo-Cell International
Cryogene Lab
CryoLogic
Cryo-Save
Cureline
Custom Biogenic Systems
Cybrdi
Cybrdi
DeCODE Genetics (Amgen)
Eli Lilly
ENGAGE
Eppendorf
Esco
ESFRI
Fisher Bio Services
FluidX
Future Health Biobank
GE Healthcare SeqWright Genomic Services
GEN2PHEN
Genentech
Gilson
GlaxoSmithKline
Haier Biomedical
Hamilton Robotics
Hamilton Storage Technologies
Hospital Necker Paris
Hudson Robotics
Hungarian Biobank
Huntington Disease Biobank
In biomed
Indivumed
Infectious Disease Biobank
IntegenX
International Stem Cell Corporation
Kaiser Permanente
King’s College London Tissue Bank
Lab ware
LABVANTAGE
Leiden Longevity
Leiden University Medical Center
Life Bank USA
Life Gene
Life Lines Biobank
Malm? Microbiology Biobank
Merck
Micronics
Mitochondrial Disease Biobank
NESDA
Novare Biologistics
Novartis
Ocimum Bio solutions
OnCore UK
Organisation for Economic Co-operation and Development (OECD)
OriGene
Pacific Bio Storage
PALGA
Panasonic Biomedical
Parelsnoer
PerkinElmer
Pfizer
Pharma Cells
PHOEBE
Pop-Gen National Cohort
Precious Cells
Precision Bio services
PrecisionMed
PREVEND
Progenicyte
ProMedDx
ProteoGenex
Qiagen
Riken BRC Cell Bank
Roche
Sapien Biosciences
ScÈil
Smart Cells
StarLIMS
Steelgate
Stem Life
Stem Save
Stemcyte
System Biosciences
Taiyo Nippon Sanso
TAP Bio systems (now owned by Sartorius Stedim Biotech)
TCG Life Sciences Tissue Bank
Tecan
Thermo Fisher Scientific
TISS-EU Project
Tissue Solutions
TTP Labtech
UCL Biobank
US Biomax
Via Cord
Virgin Health Bank<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Visiongain Limited
Contact Person:<\/strong> Sara Peerun
Email:<\/strong> sara.peerun@visiongain.com
Phone:<\/strong> +44 207 3366100
Address:<\/strong>143 Airport House, Purley way
City:<\/strong> London CR0 0XZ
Country:<\/strong> United Kingdom
Website:<\/strong> https:\/\/www.visiongain.com\/Report\/1970\/Biobanking-Market-Forecasts-2017-2027<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

“Biobanking for Therapeutic Use Revenue.” Our 259-page report provides 144 tables, charts, clearly illustrating the data presented in this research. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-176504","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/176504","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=176504"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/176504\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=176504"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=176504"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=176504"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}